EX-23.1 2 ex23-1.htm CONSENT

 

GlaxoSmithKline plc 11-K

 

Exhibit 23.1

 

 

Deloitte & Touche LLP
1700 Market Street
Suite 2700
Philadelphia, PA 19103
USA

 

Tel:+1 215 246 2300
Fax:+1 215 569 2441
www.deloitte.com

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statements No. 333-235651 and 333-162702 of GlaxoSmithKline PLC on Form S-8s of our report dated June 8, 2021, relating to the financial statements and supplemental schedule of GSK 401(k) Plan appearing in this Annual Report on Form 11-K of GSK 401(k) Plan for the year ended December 31, 2020.

 

 

Philadelphia, Pennsylvania

 

June 8, 2021